Cita APA

MC, G., J, K., M, R., C, C., H, B., N, R., . . . C, F. (2025). Durvalumab after sequential chemoradiotherapy in unresectable stage III non-small-cell lung cancer-final analysis from the phase II PACIFIC-6 trial.

Citación estilo Chicago

MC, Garassino, et al. Durvalumab After Sequential Chemoradiotherapy in Unresectable Stage III Non-small-cell Lung Cancer-final Analysis From the Phase II PACIFIC-6 Trial. 2025.

Cita MLA

MC, Garassino, et al. Durvalumab After Sequential Chemoradiotherapy in Unresectable Stage III Non-small-cell Lung Cancer-final Analysis From the Phase II PACIFIC-6 Trial. 2025.

Precaución: Estas citas no son 100% exactas.